Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Arnold

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Heart, Lung & Circulation|August 15, 2021
In Hospital Outcomes for High-Risk Percutaneous Coronary Intervention (PCI) in Patients Referred From a Rural Centre to Metropolitan SitesRajan Rehan, Elise Kempler, Kath McMaster, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
8-Aryl xanthines potent inhibitors of phosphodiesterase 5Ruth Arnold, David Beer, Gurdip Bhalay, et al.
The Medical Journal of Australia|August 1, 2020
Cardiovascular disease and COVID-19: Australian and New Zealand consensus statementSarah Zaman, Andrew I MacIsaac, Garry Lr Jennings, et al.
European Heart Journal|March 6, 2025
The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrenceQuan M Dang, Peter J Psaltis, Sonya Burgess, et al.
Heart, Lung & Circulation|March 13, 2026
Health-Related Quality-of-Life and its Determinants After Acute Coronary Syndrome Caused by Spontaneous Coronary Artery DissectionQuan M Dang, Mithila Zaheen, Patrick Pender, et al.
Journal of the American Heart Association|February 26, 2026
Spontaneous Coronary Artery Dissection: Sex Differences in Clinical Presentation and Outcomes From the Australian New Zealand RegistryFergal T Temple, Quan Dang, Sonya Burgess, et al.
Heart (British Cardiac Society)|April 20, 2026
Ethnicity and its impact on presentation and outcomes in patients with spontaneous coronary artery dissection from the Australian-New Zealand registryHansaem Jung, Masoud S Haghighi, Quan Dang, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2007
Potent and selective xanthine-based inhibitors of phosphodiesterase 5Nichola J Arnold, Ruth Arnold, David Beer, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Heart, Lung & Circulation|August 15, 2021
In Hospital Outcomes for High-Risk Percutaneous Coronary Intervention (PCI) in Patients Referred From a Rural Centre to Metropolitan SitesRajan Rehan, Elise Kempler, Kath McMaster, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
8-Aryl xanthines potent inhibitors of phosphodiesterase 5Ruth Arnold, David Beer, Gurdip Bhalay, et al.
The Medical Journal of Australia|August 1, 2020
Cardiovascular disease and COVID-19: Australian and New Zealand consensus statementSarah Zaman, Andrew I MacIsaac, Garry Lr Jennings, et al.
European Heart Journal|March 6, 2025
The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrenceQuan M Dang, Peter J Psaltis, Sonya Burgess, et al.
Heart, Lung & Circulation|March 13, 2026
Health-Related Quality-of-Life and its Determinants After Acute Coronary Syndrome Caused by Spontaneous Coronary Artery DissectionQuan M Dang, Mithila Zaheen, Patrick Pender, et al.
Journal of the American Heart Association|February 26, 2026
Spontaneous Coronary Artery Dissection: Sex Differences in Clinical Presentation and Outcomes From the Australian New Zealand RegistryFergal T Temple, Quan Dang, Sonya Burgess, et al.
Heart (British Cardiac Society)|April 20, 2026
Ethnicity and its impact on presentation and outcomes in patients with spontaneous coronary artery dissection from the Australian-New Zealand registryHansaem Jung, Masoud S Haghighi, Quan Dang, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2007
Potent and selective xanthine-based inhibitors of phosphodiesterase 5Nichola J Arnold, Ruth Arnold, David Beer, et al.
Pageof 2